These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11546949)

  • 1. Access to antiretroviral therapy in HIV-infected injection drug users.
    Antela A
    AIDS; 2001 Sep; 15(13):1727-8. PubMed ID: 11546949
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiretroviral therapy for drug users.
    Clarke SM; Mulcahy FM
    Int J STD AIDS; 2000 Oct; 11(10):627-31. PubMed ID: 11057932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users.
    Celentano DD; Galai N; Sethi AK; Shah NG; Strathdee SA; Vlahov D; Gallant JE
    AIDS; 2001 Sep; 15(13):1707-15. PubMed ID: 11546947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What's new for injection drug users with HIV infection?
    Clarke SM; Mulcahy FM
    Sex Transm Infect; 2003 Apr; 79(2):80-3. PubMed ID: 12690121
    [No Abstract]   [Full Text] [Related]  

  • 5. Universal access to HIV/AIDS treatment for injecting drug users: keeping the promise.
    Ball AL
    Int J Drug Policy; 2007 Aug; 18(4):241-5. PubMed ID: 17689371
    [No Abstract]   [Full Text] [Related]  

  • 6. Debate on the paper by David Vlahov & David D. Celentano. HIV infection, injection drug users and bioethics.
    Palácios M
    Cad Saude Publica; 2006 Apr; 22(4):725-6; author reply 730-1. PubMed ID: 16612423
    [No Abstract]   [Full Text] [Related]  

  • 7. Barriers to use of free antiretroviral therapy in injection drug users.
    Strathdee SA; Palepu A; Cornelisse PG; Yip B; O'Shaughnessy MV; Montaner JS; Schechter MT; Hogg RS
    JAMA; 1998 Aug; 280(6):547-9. PubMed ID: 9707146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview.
    Lert F; Kazatchkine MD
    Int J Drug Policy; 2007 Aug; 18(4):255-61. PubMed ID: 17689373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?' A comparison between patients' self-reports and serum protease inhibitor concentrations in the French Manif 2000 cohort study.
    Duran S; Solas C; Spire B; Carrieri MP; Fuzibet JG; Costagliola D; Lacarelle B; Moatti JP;
    AIDS; 2001 May; 15(8):1075-7. PubMed ID: 11399998
    [No Abstract]   [Full Text] [Related]  

  • 10. Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users.
    Wood E; Kerr T; Zhang R; Guillemi S; Palepu A; Hogg RS; Montaner JS
    HIV Med; 2008 Aug; 9(7):503-7. PubMed ID: 18484977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nevirapine/didanosine/lamivudine once daily in HIV-1-infected intravenous drug users.
    Staszewski S; Haberl A; Gute P; Nisius G; Miller V; Carlebach A
    Antivir Ther; 1998; 3 Suppl 4():55-6. PubMed ID: 10723511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment. Injection drug users have poor access to HIV care, study finds.
    AIDS Policy Law; 2010 Apr; 25(5):3. PubMed ID: 20564805
    [No Abstract]   [Full Text] [Related]  

  • 13. Access to highly active antiretroviral therapy (HAART) for injecting drug users in the WHO European Region 2002-2004.
    Donoghoe MC; Bollerup AR; Lazarus JV; Nielsen S; Matic S
    Int J Drug Policy; 2007 Aug; 18(4):271-80. PubMed ID: 17689375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of barriers and facilitators of HIV treatment among injection drug users.
    Wood E; Kerr T; Tyndall MW; Montaner JS
    AIDS; 2008 Jul; 22(11):1247-56. PubMed ID: 18580603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users.
    Gibson DR; Flynn NM; McCarthy JJ
    AIDS; 1999 Oct; 13(14):1807-18. PubMed ID: 10513638
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term outcomes of protease inhibitor-based therapy in antiretroviral treatment-naive HIV-infected injection drug users on methadone maintenance programmes.
    Moreno A; Perez-Elías MJ; Casado JL; Muñoz V; Antela A; Dronda F; Navas E; Moreno S
    AIDS; 2001 May; 15(8):1068-70. PubMed ID: 11399995
    [No Abstract]   [Full Text] [Related]  

  • 17. Medication-assisted treatment and HIV/AIDS: aspects in treating HIV-infected drug users.
    Bruce RD; Kresina TF; McCance-Katz EF
    AIDS; 2010 Jan; 24(3):331-40. PubMed ID: 19910788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic interactions of nevirapine and methadone and guidelines for use of nevirapine to treat injection drug users.
    Clarke SM; Mulcahy FM; Tjia J; Reynolds HE; Gibbons SE; Barry MG; Back DJ
    Clin Infect Dis; 2001 Nov; 33(9):1595-7. PubMed ID: 11568856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward.
    Wolfe D; Carrieri MP; Shepard D
    Lancet; 2010 Jul; 376(9738):355-66. PubMed ID: 20650513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral therapy: a key part of the public health response to injection drug use.
    Wood E; Montaner JS
    Addiction; 2008 Apr; 103(4):660-1. PubMed ID: 18339111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.